Monthly Archives: October 2022
Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism.
Baidildinova G, Ten Cate V, Nagler M, Panova-Noeva M, Rapp S, Köck T, Prochaska JH, Heitmeier S, Gerdes C, Schwers S, Konstantinides SV, Münzel T, Espinola-Klein C, Lackner KJ, Spronk HMN, Ten Cate H, van der Meijden PEJ, Leineweber K, … Continue reading
Posted in publications
Leave a comment
Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort.
an de Berg TW, Mulder MMG, Alnima T, Nagy M, van Oerle R, Beckers EAM, Hackeng TM, Hulshof AM, Sels JEM, Henskens YMC, van der Horst ICC, Ten Cate H, Spronk HMH, van Bussel BCT; MaastrICCht Collaborators. Front Cardiovasc Med. … Continue reading
Posted in publications
Leave a comment
Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial.
Willems LH, Thijssen DHJ, Groh LA, Kooijman NI, Ten Cate H, Spronk HMH, Donders ART, van der Vijver-Coppen RJ, van Hoek F, Nagy M, Reijnen MMPJ, Warlé MC. Front Cardiovasc Med. 2022 Oct 6;9:979819. PMID: 36277757 Objective: Dual pathway inhibition … Continue reading
Posted in publications
Leave a comment